T follicular helper cells in human autoimmunity

Current Opinion in Immunology

Volumn 43, Issue , 2016, Pages 24-31

  Ueno, Hideki ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; BIOLOGICAL MARKER; CHEMOKINE RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 6; PROGRAMMED DEATH 1 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; AUTOANTIBODY; ICOS PROTEIN, HUMAN; INDUCIBLE T CELL COSTIMULATOR; PDCD1 PROTEIN, HUMAN;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; DENDRITIC CELL; GERMINAL CENTER; HELPER CELL; HUMAN; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; PATHOGENESIS; REVIEW; T FOLLICULAR HELPER CELL; BIOSYNTHESIS; CELL DIFFERENTIATION; IMMUNOLOGY; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; CELL DIFFERENTIATION; GERMINAL CENTER; HUMANS; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; INFLAMMATION; PROGRAMMED CELL DEATH 1 RECEPTOR; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84984659270     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2016.08.003     Document Type: Review

References (75)

1. 1 Ueno, H., Banchereau, J., Vinuesa, C.G., Pathophysiology of T follicular helper cells in humans and mice. Nat Immunol 16 (2015), 142–152.
2. 2 Vinuesa, C.G., Linterman, M.A., Yu, D., MacLennan, I.C., Follicular helper T cells. Annu Rev Immunol 34 (2016), 335–368.
3. 3 Crotty, S., T follicular helper cell differentiation, function, and roles in disease. Immunity 41 (2014), 529–542.
4. 4 Ma, C.S., Deenick, E.K., Batten, M., Tangye, S.G., The origins, function, and regulation of T follicular helper cells. J Exp Med 209 (2012), 1241–1253.
5. 5 MacLennan, I.C., Toellner, K.M., Cunningham, A.F., Serre, K., Sze, D.M., Zuniga, E., Cook, M.C., Vinuesa, C.G., Extrafollicular antibody responses. Immunol Rev 194 (2003), 8–18.
6. 6 Victora, G.D., Nussenzweig, M.C., Germinal centers. Annu Rev Immunol 30 (2012), 429–457.
7. 7 Victora, G.D., Schwickert, T.A., Fooksman, D.R., Kamphorst, A.O., Meyer-Hermann, M., Dustin, M.L., Nussenzweig, M.C., Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 143 (2010), 592–605.
8. 8 Amara, K., Steen, J., Murray, F., Morbach, H., Fernandez-Rodriguez, B.M., Joshua, V., Engstrom, M., Snir, O., Israelsson, L., Catrina, A.I., et al. Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J Exp Med 210 (2013), 445–455.
9. 9 Mietzner, B., Tsuiji, M., Scheid, J., Velinzon, K., Tiller, T., Abraham, K., Gonzalez, J.B., Pascual, V., Stichweh, D., Wardemann, H., et al. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci U S A 105 (2008), 9727–9732.
10. 10 Heesters, B.A., Myers, R.C., Carroll, M.C., Follicular dendritic cells: dynamic antigen libraries. Nat Rev Immunol 14 (2014), 495–504.
11. 11 Schmitt, N., Bentebibel, S.E., Ueno, H., Phenotype and functions of memory Tfh cells in human blood. Trends Immunol 35 (2014), 436–442.
12. 12 Morita, R., Schmitt, N., Bentebibel, S.E., Ranganathan, R., Bourdery, L., Zurawski, G., Foucat, E., Dullaers, M., Oh, S., Sabzghabaei, N., et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34 (2011), 108–121.
13. 13 Locci, M., Havenar-Daughton, C., Landais, E., Wu, J., Kroenke, M.A., Arlehamn, C.L., Su, L.F., Cubas, R., Davis, M.M., Sette, A., et al. Human circulating PD-1(+)CXCR3(−)CXCR5(+) memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 39 (2013), 758–769.
14. 14 He, J., Tsai, L.M., Leong, Y.A., Hu, X., Ma, C.S., Chevalier, N., Sun, X., Vandenberg, K., Rockman, S., Ding, Y., et al. Circulating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 39 (2013), 770–781.
15. 15 Choi, J.Y., Ho, J.H., Pasoto, S.G., Bunin, V., Kim, S.T., Carrasco, S., Borba, E.F., Goncalves, C.R., Costa, P.R., Kallas, E.G., et al. Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol 67 (2015), 988–999.
16. 16 Simpson, N., Gatenby, P.A., Wilson, A., Malik, S., Fulcher, D.A., Tangye, S.G., Manku, H., Vyse, T.J., Roncador, G., Huttley, G.A., et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum 62 (2010), 234–244.
17. 17 Akiyama, M., Suzuki, K., Yamaoka, K., Yasuoka, H., Takeshita, M., Kaneko, Y., Kondo, H., Kassai, Y., Miyazaki, T., Morita, R., et al. Number of circulating follicular helper 2 T cells correlates with IgG4 and interleukin-4 levels and plasmablast numbers in IgG4-related disease. Arthritis Rheumatol 67 (2015), 2476–2481.
18. 18 Li, X.Y., Wu, Z.B., Ding, J., Zheng, Z.H., Li, X.Y., Chen, L.N., Zhu, P., Role of the frequency of blood CD4(+) CXCR5(+) CCR6(+) T cells in autoimmunity in patients with Sjogren's syndrome. Biochem Biophys Res Commun 422 (2012), 238–244.
19. 19 Wang, J., Shan, Y., Jiang, Z., Feng, J., Li, C., Ma, L., Jiang, Y., High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis. Clin Exp Immunol 174 (2013), 212–220.
20. 20 Liu, R., Wu, Q., Su, D., Che, N., Chen, H., Geng, L., Chen, J., Chen, W., Li, X., Sun, L., A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis. Arthritis Res Ther, 14, 2012, R255.
21. 21 Arroyo-Villa, I., Bautista-Caro, M.B., Balsa, A., Aguado-Acin, P., Bonilla-Hernan, M.G., Plasencia, C., Villalba, A., Nuno, L., Puig-Kroger, A., Martin-Mola, E., et al. Constitutively altered frequencies of circulating follicullar helper T cell counterparts and their subsets in rheumatoid arthritis. Arthritis Res Ther, 16, 2014, 500.
22. 22 Zhu, C., Ma, J., Liu, Y., Tong, J., Tian, J., Chen, J., Tang, X., Xu, H., Lu, L., Wang, S., Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 97 (2012), 943–950.
23. 23 Xu, X., Shi, Y., Cai, Y., Zhang, Q., Yang, F., Chen, H., Gu, Y., Zhang, M., Yu, L., Yang, T., Inhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes. PLoS ONE, 8, 2013, e79858.
24. 24 Kenefeck, R., Wang, C.J., Kapadi, T., Wardzinski, L., Attridge, K., Clough, L.E., Heuts, F., Kogimtzis, A., Patel, S., Rosenthal, M., et al. Follicular helper T cell signature in type 1 diabetes. J Clin Invest 125 (2015), 292–303.
25. 25 Xie, J., Cui, D., Liu, Y., Jin, J., Tong, H., Wang, L., Ruan, G., Lu, Y., Yuan, H., Changes in follicular helper T cells in idiopathic thrombocytopenic purpura patients. Int J Biol Sci 11 (2015), 220–229.
26. 26 Luo, C., Li, Y., Liu, W., Feng, H., Wang, H., Huang, X., Qiu, L., Ouyang, J., Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis. J Neuroimmunol 256 (2013), 55–61.
27. 27 Zhang, X., Liu, S., Chang, T., Xu, J., Zhang, C., Tian, F., Sun, Y., Song, C., Yi, W., Lin, H., et al. Intrathymic Tfh/B cells interaction leads to ectopic GCs formation and anti-AChR antibody production: central role in triggering MG occurrence. Mol Neurobiol 53 (2016), 120–131.
28. 28 Fan, X., Jiang, Y., Han, J., Liu, J., Wei, Y., Jiang, X., Jin, T., Circulating memory T follicular helper cells in patients with neuromyelitis optica/neuromyelitis optica spectrum disorders. Mediat Inflamm, 2016, 2016, 3678152.
29. 29 Che, Y., Qiu, J., Jin, T., Yin, F., Li, M., Jiang, Y., Circulating memory T follicular helper subsets, Tfh2 and Tfh17, participate in the pathogenesis of Guillain–Barre syndrome. Sci Rep, 6, 2016, 20963.
30. 30• Havenar-Daughton, C., Lindqvist, M., Heit, A., Wu, J.E., Reiss, S.M., Kendric, K., Belanger, S., Kasturi, S.P., Landais, E., Akondy, R.S., et al. CXCL13 is a plasma biomarker of germinal center activity. Proc Natl Acad Sci U S A 113 (2016), 2702–2707 This study showed that plasma CXCL13 concentrations positively correlated with GC frequencies in immunized mice, immunized macaques, and HIV-infected humans. This study proposed plasma CXCL13 as a biomarker for GC activity.
31. 31 Schiffer, L., Worthmann, K., Haller, H., Schiffer, M., CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis – from bench to bedside?. Clin Exp Immunol 179 (2015), 85–89.
32. 32 Bugatti, S., Manzo, A., Benaglio, F., Klersy, C., Vitolo, B., Todoerti, M., Sakellariou, G., Montecucco, C., Caporali, R., Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs. Arthritis Res Ther, 14, 2012, R34.
33. 33 Greisen, S.R., Schelde, K.K., Rasmussen, T.K., Kragstrup, T.W., Stengaard-Pedersen, K., Hetland, M.L., Horslev-Petersen, K., Junker, P., Ostergaard, M., Deleuran, B., et al. CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic ‘window of opportunity’. Arthritis Res Ther, 16, 2014, 434.
34. 34• Bugatti, S., Manzo, A., Vitolo, B., Benaglio, F., Binda, E., Scarabelli, M., Humby, F., Caporali, R., Pitzalis, C., Montecucco, C., High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease. Rheumatology (Oxford) 53 (2014), 1886–1895 This study showed that CXCL13 expression in RA synovial tissues correlated with local disease activity and systemic inflammation, in particular in patients with early disease (<12 months duration).
35. 35 Nishikawa, A., Suzuki, K., Kassai, Y., Gotou, Y., Takiguchi, M., Miyazaki, T., Yoshimoto, K., Yasuoka, H., Yamaoka, K., Morita, R., et al. Identification of definitive serum biomarkers associated with disease activity in primary Sjogren's syndrome. Arthritis Res Ther, 18, 2016, 106.
36. 36 Pitzalis, C., Jones, G.W., Bombardieri, M., Jones, S.A., Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol 14 (2014), 447–462.
37. 37• Canete, J.D., Celis, R., Yeremenko, N., Sanmarti, R., van Duivenvoorde, L., Ramirez, J., Blijdorp, I., Garcia-Herrero, C.M., Pablos, J.L., Baeten, D.L., Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis. Arthritis Res Ther, 17, 2015, 173 This study showed that IL-23 was highly expressed by RA synovial tissues with ectopic GCs. IL-23 expression also positively correlated with the expression of IL-21 as well as IL-17F and IL-22, suggesting the key role of IL-23 for T cell activation in synovial tissues in RA.
38. 38•• Delli, K., Haacke, E.A., Kroese, F.G., Pollard, R.P., Ihrler, S., van der Vegt, B., Vissink, A., Bootsma, H., Spijkervet, F.K., Towards personalised treatment in primary Sjogren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment. Ann Rheum Dis, 2016 This study showed that treatment with rituximab decreased the number and the size of ectopic GCs in Sjogren's syndrome patients. Furthermore, it showed that patients with larger number of ectopic GCs responded better to rituximab.
39. 39 Vincent, A., Palace, J., Hilton-Jones, D., Myasthenia gravis. Lancet 357 (2001), 2122–2128.
40. 40 Kinloch, A.J., Chang, A., Ko, K., Henry Dunand, C.J., Henderson, S., Maienschein-Cline, M., Kaverina, N., Rovin, B.H., Salgado Ferrer, M., Wolfgeher, D., et al. Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis. Arthritis Rheumatol 66 (2014), 3359–3370.
41. 41 Weyand, C.M., Goronzy, J.J., Ectopic germinal center formation in rheumatoid synovitis. Ann N Y Acad Sci 987 (2003), 140–149.
42. 42 Ekland, E.H., Forster, R., Lipp, M., Cyster, J.G., Requirements for follicular exclusion and competitive elimination of autoantigen-binding B cells. J Immunol 172 (2004), 4700–4708.
43. 43 Liarski, V.M., Kaverina, N., Chang, A., Brandt, D., Yanez, D., Talasnik, L., Carlesso, G., Herbst, R., Utset, T.O., Labno, C., et al. Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci Transl Med, 6, 2014, 230ra246.
44. 44 Zuckerman, N.S., Howard, W.A., Bismuth, J., Gibson, K., Edelman, H., Berrih-Aknin, S., Dunn-Walters, D., Mehr, R., Ectopic GC in the thymus of myasthenia gravis patients show characteristics of normal GC. Eur J Immunol 40 (2010), 1150–1161.
45. 45 Thurlings, R.M., Wijbrandts, C.A., Mebius, R.E., Cantaert, T., Dinant, H.J., van der Pouw-Kraan, T.C., Verweij, C.L., Baeten, D., Tak, P.P., Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype. Arthritis Rheum 58 (2008), 1582–1589.
46. 46 Maehara, T., Moriyama, M., Hayashida, J.N., Tanaka, A., Shinozaki, S., Kubo, Y., Matsumura, K., Nakamura, S., Selective localization of T helper subsets in labial salivary glands from primary Sjogren's syndrome patients. Clin Exp Immunol 169 (2012), 89–99.
47. 47 Kobayashi, S., Murata, K., Shibuya, H., Morita, M., Ishikawa, M., Furu, M., Ito, H., Ito, J., Matsuda, S., Watanabe, T., et al. A distinct human CD4+ T cell subset that secretes CXCL13 in rheumatoid synovium. Arthritis Rheum 65 (2013), 3063–3072.
48. + Tfh-like cells in synovial tissues in RA patients did not express CXCR5, ICOS, or Bcl-6.
49. 49 McGuire, H.M., Vogelzang, A., Ma, C.S., Hughes, W.E., Silveira, P.A., Tangye, S.G., Christ, D., Fulcher, D., Falcone, M., King, C., A subset of interleukin-21+ chemokine receptor CCR9+ T helper cells target accessory organs of the digestive system in autoimmunity. Immunity 34 (2011), 602–615.
50. 50 Schmitt, N., Morita, R., Bourdery, L., Bentebibel, S.E., Zurawski, S.M., Banchereau, J., Ueno, H., Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity 31 (2009), 158–169.
51. 51 Ma, C.S., Suryani, S., Avery, D.T., Chan, A., Nanan, R., Santner-Nanan, B., Deenick, E.K., Tangye, S.G., Early commitment of naive human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12. Immunol Cell Biol 87 (2009), 590–600.
52. 52 Schmitt, N., Bustamante, J., Bourdery, L., Bentebibel, S.E., Boisson-Dupuis, S., Hamlin, F., Tran, M.V., Blankenship, D., Pascual, V., Savino, D.A., et al. IL-12 receptor beta1 deficiency alters in vivo T follicular helper cell response in humans. Blood 121 (2013), 3375–3385.
53. + T cells.
54. 54 Ma, C.S., Avery, D.T., Chan, A., Batten, M., Bustamante, J., Boisson-Dupuis, S., Arkwright, P.D., Kreins, A.Y., Averbuch, D., Engelhard, D., et al. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood 119 (2012), 3997–4008.
55. 55•• Locci, M., Wu, J.E., Arumemi, F., Mikulski, Z., Dahlberg, C., Miller, A.T., Crotty, S., Activin A programs the differentiation of human TFH cells. Nat Immunol, 17, 2016 This study shows Activin A, a TGF-β superfamily molecule, is another key cytokine for Tfh cell differentiation in humans.
56. 56 Akiba, H., Takeda, K., Kojima, Y., Usui, Y., Harada, N., Yamazaki, T., Ma, J., Tezuka, K., Yagita, H., Okumura, K., The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo. J Immunol 175 (2005), 2340–2348.
57. 57 Bossaller, L., Burger, J., Draeger, R., Grimbacher, B., Knoth, R., Plebani, A., Durandy, A., Baumann, U., Schlesier, M., Welcher, A.A., et al. ICOS deficiency is associated with a severe reduction of CXCR5+ CD4 germinal center Th cells. J Immunol 177 (2006), 4927–4932.
58. 58 Choi, Y.S., Kageyama, R., Eto, D., Escobar, T.C., Johnston, R.J., Monticelli, L., Lao, C., Crotty, S., ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 34 (2011), 932–946.
59. 59 Xu, H., Li, X., Liu, D., Li, J., Zhang, X., Chen, X., Hou, S., Peng, L., Xu, C., Liu, W., et al. Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature 496 (2013), 523–527.
60. 60 Hutloff, A., Dittrich, A.M., Beier, K.C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., Kroczek, R.A., ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397 (1999), 263–266.
61. 61 Vogelzang, A., McGuire, H.M., Yu, D., Sprent, J., Mackay, C.R., King, C., A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 29 (2008), 127–137.
62. 62• Jacquemin, C., Schmitt, N., Contin-Bordes, C., Liu, Y., Narayanan, P., Seneschal, J., Maurouard, T., Dougall, D., Davizon, E.S., Dumortier, H., et al. OX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response. Immunity 42 (2015), 1159–1170 This study showed that the OX40L-OX40 axis is involved in exaggerated Tfh response in human SLE.
63. 63 Byun, M., Ma, C.S., Akcay, A., Pedergnana, V., Palendira, U., Myoung, J., Avery, D.T., Liu, Y., Abhyankar, A., Lorenzo, L., et al. Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. J Exp Med 210 (2013), 1743–1759.
64. 64 Lyakh, L., Trinchieri, G., Provezza, L., Carra, G., Gerosa, F., Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol Rev 226 (2008), 112–131.
65. 65 Schmitt, N., Liu, Y., Bentebibel, S.E., Ueno, H., Molecular mechanisms regulating T helper 1 versus T follicular helper cell differentiation in humans. Cell Rep, 16, 2016.
66. 66 Fava, R., Olsen, N., Keski-Oja, J., Moses, H., Pincus, T., Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med 169 (1989), 291–296.
67. + T cells to upregulate CXCL13 expression. Both cytokines are upregulated in RA synovial tissues, suggesting the involvement of CXCL13 production in situ.
68. 68 Xia, Y., Schneyer, A.L., The biology of activin: recent advances in structure, regulation and function. J Endocrinol 202 (2009), 1–12.
69. 69 Robson, N.C., Phillips, D.J., McAlpine, T., Shin, A., Svobodova, S., Toy, T., Pillay, V., Kirkpatrick, N., Zanker, D., Wilson, K., et al. Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production. Blood 111 (2008), 2733–2743.
70. 70 Soler Palacios, B., Estrada-Capetillo, L., Izquierdo, E., Criado, G., Nieto, C., Municio, C., Gonzalez-Alvaro, I., Sanchez-Mateos, P., Pablos, J.L., Corbi, A.L., et al. Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile. J Pathol 235 (2015), 515–526.
71. 71 Stranger, B.E., De Jager, P.L., Coordinating GWAS results with gene expression in a systems immunologic paradigm in autoimmunity. Curr Opin Immunol 24 (2012), 544–551.
72. 72 Batten, M., Ramamoorthi, N., Kljavin, N.M., Ma, C.S., Cox, J.H., Dengler, H.S., Danilenko, D.M., Caplazi, P., Wong, M., Fulcher, D.A., et al. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. J Exp Med 207 (2010), 2895–2906.
73. 73 Gringhuis, S.I., Kaptein, T.M., Wevers, B.A., van der Vlist, M., Klaver, E.J., van Die, I., Vriend, L.E., de Jong, M.A., Geijtenbeek, T.B., Fucose-based PAMPs prime dendritic cells for follicular T helper cell polarization via DC-SIGN-dependent IL-27 production. Nat Commun, 5, 2014, 5074.
74. 74•• Jones, G.W., Bombardieri, M., Greenhill, C.J., McLeod, L., Nerviani, A., Rocher-Ros, V., Cardus, A., Williams, A.S., Pitzalis, C., Jenkins, B.J., et al. Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis. J Exp Med 212 (2015), 1793–1802 This study suggests that IL-27 inhibits the formation of ectopic GCs in inflamed tissues. In contrast to Ref. [36], this study showed that IL-27 expression in RA synovial tissues negatively correlated with T and B cell infiltration and ectopic GC formation.
75. 75 Yoshida, H., Hunter, C.A., The immunobiology of interleukin-27. Annu Rev Immunol 33 (2015), 417–443.